Pharmacology and molecular identification of vasoactive intestinal peptide (VIP) receptors in normal and cancerous gastric mucosa in man
- 1 March 1988
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 151 (2) , 939-947
- https://doi.org/10.1016/s0006-291x(88)80372-3
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Pharmacology and molecular identification of secretin receptors in rat gastric glandsLife Sciences, 1988
- Secretin receptor activity in rat gastric glands. Binding studies, cAMP generation and pharmacologyPeptides, 1986
- Functional receptors for VIP, GIP, Glucagon-29 and -37 in the HGT-1 human gastric cancer cell linePeptides, 1986
- The biological relevance of HPLC-purified vasoactive intestinal polypeptide monoiodinated at tyrosine 10 or tyrosine 22Regulatory Peptides, 1985
- Covalent cross‐linking of vasoactive intestinal peptide (VIP) to its receptor in intact colonic adenocarcinoma cells in culture (HT 29)European Journal of Biochemistry, 1985
- Molecular identification of receptors for vasoactive intestinal peptide in rat intestinal epithelium by covalent cross‐linkingEuropean Journal of Biochemistry, 1984
- Purification of a novel pancreatic secretory factor (PSF) and a novel peptide with VIP‐ and secretin‐like properties (helodermin) from Gila monster venomFEBS Letters, 1984
- Histamine and VIP interactions with receptor-cyclic AMP systems in the human gastric cancer cell line HGT-1Life Sciences, 1983
- Evidence for a cyclic AMP system highly sensitive to secretin in gastric glands isolated from the rat fundus and antrumBiochimica et Biophysica Acta (BBA) - General Subjects, 1980
- Regulation by vasoactive intestinal peptide of cyclic amp accumulation in gastric epithelial glandsFEBS Letters, 1980